GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

This included both nonprescription and prescription drugs obtained ... ADR but forgotten to report it during the initial interview. If there was no report of the adverse reaction in the progress ...

The detection of adverse drug reactions (ADRs) by a traditional passive reporting system and by a method involving patient and provider interviews was studied. The study sample consisted of ...

On January 20, 2025, my team published a study of more than 2.4 million people that evaluated the risks and benefits of ... effects of GLP-1 drugs in reducing risks of adverse cardiovascular ...

However, adverse drug reactions (ADRs) associated with emerging anti-fibrotic ... Disproportionality analysis, measured by reporting odd ratio (ROR) and proportional reporting ratio (PRR), was ...

Other benefits: Lower rates of liver cancer, kidney disease and bacterial infections. The study reported a 12 per cent reduction in Alzheimer’s risk after just 3.5 years of using these drugs, despite ...

MONTGOMERY, Ala. (WTVA) — The Alabama Department of Public Health (ADPH) is investigating reports of adverse reactions to injections of the antibiotic ceftriaxone, also known as Rocephin. The ADPH ...

The study in Nature Medicine explores the potential wider benefits and risks of diabetes drugs GLP-1 receptor agonists. Besides weight loss, these drugs might reduce risks for neurocognitive disorders ...